These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2037132)
1. Probing the platelet plasma-membrane 5-hydroxytryptamine transporter. Williams DC; Phillips OM Biochem Soc Trans; 1991 Feb; 19(1):112-4. PubMed ID: 2037132 [No Abstract] [Full Text] [Related]
2. The design of photo-affinity labels for the characterisation of the 5-hydroxytryptamine transporter on human platelet membranes. Maher WJ; Phillips OM; Williams DC Biochem Soc Trans; 1991 Feb; 19(1):10S. PubMed ID: 2037129 [No Abstract] [Full Text] [Related]
3. Approaches to the purification of the 5-hydroxytryptamine reuptake system from human blood platelets. Biessen EA; Horn AS; Robillard GT Biochem Soc Trans; 1991 Feb; 19(1):103-11. PubMed ID: 2037130 [No Abstract] [Full Text] [Related]
4. Substrate and inhibitor binding and translocation by the platelet plasma membrane serotonin transporter. Humphreys CJ; Beidler D; Rudnick G Biochem Soc Trans; 1991 Feb; 19(1):95-8. PubMed ID: 2037207 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport. Talvenheimo J; Nelson PJ; Rudnick G J Biol Chem; 1979 Jun; 254(11):4631-5. PubMed ID: 438209 [TBL] [Abstract][Full Text] [Related]
13. Dithiothreithol promotes a higher affinity state of the serotonin transporter for the tricyclic antidepressant, imipramine. Tarrant HM; Williams DC Biochem Soc Trans; 1995 Feb; 23(1):41S. PubMed ID: 7758754 [No Abstract] [Full Text] [Related]
14. Changes in platelet 3-H-imipramine binding: influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents used. Rosel-Soria P; Vallejo J; Oros M; Serrallonga J; Menchon JM; Navarro MA Biol Psychiatry; 1995 Oct; 38(7):464-70. PubMed ID: 8672607 [TBL] [Abstract][Full Text] [Related]
15. Long-term verapamil treatment increases [3H]imipramine binding in human platelets. Cohen A; Weizman A; Eldar M; Rehavi M Eur J Pharmacol; 1990 Jun; 181(3):311-4. PubMed ID: 2166676 [TBL] [Abstract][Full Text] [Related]
16. Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complex. Abraham KI; Ieni JR; Meyerson LR Biochim Biophys Acta; 1987 Jan; 923(1):8-21. PubMed ID: 3542053 [TBL] [Abstract][Full Text] [Related]
17. Solubilization of the platelet plasma membrane serotonin transporter in an active form. Talvenheimo J; Rudnick G J Biol Chem; 1980 Sep; 255(18):8606-11. PubMed ID: 7410380 [TBL] [Abstract][Full Text] [Related]
18. Serotonin transport by platelet plasma and granule membranes. Rudnick G; Humphreys CJ; Dean GE Ann N Y Acad Sci; 1985; 456():277-8. PubMed ID: 2418730 [No Abstract] [Full Text] [Related]
19. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier. Phillips OM; Wood KM; Williams DC Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401 [TBL] [Abstract][Full Text] [Related]
20. Sodium ion requirements for serotonin transport and imipramine binding. Rudnick G; Talvenheimo J; Fishkes H; Nelson PJ Psychopharmacol Bull; 1983; 19(3):545-9. PubMed ID: 6635128 [No Abstract] [Full Text] [Related] [Next] [New Search]